Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Chubb
Dow
Chinese Patent Office
Federal Trade Commission
Daiichi Sankyo
Baxter
US Department of Justice
McKinsey
Teva

Generated: January 21, 2018

DrugPatentWatch Database Preview

Theophylline sodium glycinate - Generic Drug Details

« Back to Dashboard

What are the generic sources for theophylline sodium glycinate and what is the scope of theophylline sodium glycinate freedom to operate?

Theophylline sodium glycinate
is the generic ingredient in two branded drugs marketed by Cent Pharms and Novartis, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-six drug master file entries for theophylline sodium glycinate.

US Patents and Regulatory Information for theophylline sodium glycinate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cent Pharms SYNOPHYLATE theophylline sodium glycinate ELIXIR;ORAL 006333-008 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novartis ASBRON theophylline sodium glycinate TABLET;ORAL 085148-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Chubb
AstraZeneca
McKesson
Chinese Patent Office
Queensland Health
Harvard Business School
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot